152 related articles for article (PubMed ID: 24640372)
1. [Expression of vascular endothelial growth factor receptor 3 in human breast cancer and its significance].
Wu J; Chen L; Zhou W; Liu X; Chen X; Miao D
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Dec; 27(12):1487-91. PubMed ID: 24640372
[TBL] [Abstract][Full Text] [Related]
2. Flt-4-positive vessel density correlates with vascular endothelial growth factor-d expression, nodal status, and prognosis in breast cancer.
Nakamura Y; Yasuoka H; Tsujimoto M; Yang Q; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
Clin Cancer Res; 2003 Nov; 9(14):5313-7. PubMed ID: 14614015
[TBL] [Abstract][Full Text] [Related]
3. [Relation of lymphatic microvessel density detected by monoclonal antibody D2-40 with VEGF-C expression in breast cancer].
Xie XD; Qu SX; Zheng ZD; Song FL; Liu DW
Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):356-60. PubMed ID: 18953835
[TBL] [Abstract][Full Text] [Related]
4. [Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy].
Wang SL; Li YX; Song YW; Wang WH; Jin J; Liu YP; Liu XF; Yu ZH
Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):520-5. PubMed ID: 21029696
[TBL] [Abstract][Full Text] [Related]
5. VEGF-D in association with VEGFR-3 promotes nodal metastasis in human invasive lobular breast cancer.
van Iterson V; Leidenius M; von Smitten K; Bono P; Heikkilä P
Am J Clin Pathol; 2007 Nov; 128(5):759-66. PubMed ID: 17951197
[TBL] [Abstract][Full Text] [Related]
6. The significance of c-erbB-2 overexpression and p53 expression in patients with axillary lymph node--negative breast cancer: a tissue microarray study.
Ko SS; Na YS; Yoon CS; Park JY; Kim HS; Hur MH; Lee HK; Chun YK; Kang SS; Park BW; Lee JH
Int J Surg Pathol; 2007 Apr; 15(2):98-109. PubMed ID: 17478762
[TBL] [Abstract][Full Text] [Related]
7. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological and prognostic significance of vascular endothelial growth factors (VEGF)-C and -D and VEGF receptor 3 in invasive breast carcinoma.
Mylona E; Alexandrou P; Mpakali A; Giannopoulou I; Liapis G; Markaki S; Keramopoulos A; Nakopoulou L
Eur J Surg Oncol; 2007 Apr; 33(3):294-300. PubMed ID: 17129704
[TBL] [Abstract][Full Text] [Related]
9. Costimulatory molecule OX40/OX40L expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.
Xie F; Wang Q; Chen Y; Gu Y; Mao H; Zeng W; Zhang X
Pathol Res Pract; 2010 Nov; 206(11):735-9. PubMed ID: 20634005
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma.
Arinaga M; Noguchi T; Takeno S; Chujo M; Miura T; Uchida Y
Cancer; 2003 Jan; 97(2):457-64. PubMed ID: 12518370
[TBL] [Abstract][Full Text] [Related]
11. Expression of vascular endothelial growth factor-C and its receptor in invasive micropapillary carcinoma of the breast.
Li YS; Kaneko M; Amatya VJ; Takeshima Y; Arihiro K; Inai K
Pathol Int; 2006 May; 56(5):256-61. PubMed ID: 16669874
[TBL] [Abstract][Full Text] [Related]
12. [Expression of vascular endothelial growth factor A and C in human breast cancer and their significance].
Hu SE; Zhang YJ; Cui YM; Zhang HQ
Ai Zheng; 2005 Sep; 24(9):1076-9. PubMed ID: 16159428
[TBL] [Abstract][Full Text] [Related]
13. Lymphatic microvessel density, VEGF-C, and VEGFR-3 expression in different molecular types of breast cancer.
Raica M; Cimpean AM; Ceausu R; Ribatti D
Anticancer Res; 2011 May; 31(5):1757-64. PubMed ID: 21617236
[TBL] [Abstract][Full Text] [Related]
14. The balance of VEGF-C and VEGFR-3 mRNA is a predictor of lymph node metastasis in non-small cell lung cancer.
Takizawa H; Kondo K; Fujino H; Kenzaki K; Miyoshi T; Sakiyama S; Tangoku A
Br J Cancer; 2006 Jul; 95(1):75-9. PubMed ID: 16755294
[TBL] [Abstract][Full Text] [Related]
15. [Clinicopathological characteristics and prognostic factors of breast cancer with estrogen- and progesterone-receptor negative and HER-2 overexpression].
Fan Y; Guan Y; Zhao WH; Li Q; Xu BH
Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):917-20. PubMed ID: 19173993
[TBL] [Abstract][Full Text] [Related]
16. [Relationship between lymph node metastasis and pathologic features of invasive micropapillary carcinoma of breast].
Guo XJ; Chen L; Lang RG; Fan Y; Fu L
Zhonghua Bing Li Xue Za Zhi; 2006 Jan; 35(1):8-12. PubMed ID: 16608641
[TBL] [Abstract][Full Text] [Related]
17. [Expression of VEGFR-2 and VEGFR-3 in papillary renal cell carcinoma and their relationship with prognosis].
Zhang YH; Diao L; Yang Q; Duo J; Liu YX; Liu SX; Yao X
Zhonghua Zhong Liu Za Zhi; 2010 Oct; 32(10):752-6. PubMed ID: 21163065
[TBL] [Abstract][Full Text] [Related]
18. [Lymphangiogenes and location of tumor lymphatic vessels induced by VEGF-C in primary breast carcer].
Huang JH; Li Y; Liu L; Yang HC; Hai J; Tang LL; Hu TH
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Feb; 31(1):36-9, 51. PubMed ID: 16562672
[TBL] [Abstract][Full Text] [Related]
19. Organotropism and prognostic marker discordance in distant metastases of breast carcinoma: fact or fiction? A clinicopathologic analysis.
St Romain P; Madan R; Tawfik OW; Damjanov I; Fan F
Hum Pathol; 2012 Mar; 43(3):398-404. PubMed ID: 21840040
[TBL] [Abstract][Full Text] [Related]
20. [Expression and clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in non-small cell lung carcinoma].
Lu ZQ; Li HG; Xie DR; Zhang HZ; Shen XM; Zeng YJ; Zeng H
Ai Zheng; 2005 Sep; 24(9):1132-5. PubMed ID: 16159440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
